In recent decades, pharmaceutical funding has been directed primarily toward drug research and development that will yield higher revenue, such as cancer drugs. But TB Alliance relied on donors from across the world to fund the development of its new tuberculosis antibiotic, and experts wonder if this is a path forward for new drugs. In other pharmaceutical news: the Norvartis data manipulation case continues, the FDA flexes its muscles, and a new treatment might help blood cancer patients.
from Kaiser Health News https://ift.tt/30sdf0l
August 23, 2019
Rose
Health News, Kaiser Health News
No comments
Related Posts:
Newly Blue Maine Expands Access To Abortion… Read More
KHN’s ‘What The Health?’: All About ‘Medicare for All’… Read More
First Edition: July 3, 2019NOTE TO READERS: KHN's First Edition will not be published July 4-5. Look for it again in your inbox July 8. Happy holidays! from Kaiser Health News https://ift.tt/2YDfFbT … Read More
American Medical Students Less Likely To Choose To Become Primary Care Doctors… Read More
Trump Raises Eyebrows With Declaration That Homelessness, Other Struggles In Cities Have Only Been Around For Two YearsWhile giving an interview with Fox News, President Donald Trump commented on the "major problem with filth" in U.S. cities, saying it's a phenomenon that emerged in recent years, despite there being ample evidence to the cont… Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment